SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001144204-19-014663
Filing Date
2019-03-18
Accepted
2019-03-18 17:02:16
Documents
1
Period of Report
2018-12-31
Effectiveness Date
2019-03-18

Document Format Files

Seq Description Document Type Size
1 NT 10-K tv516501_nt10k.htm NT 10-K 33090
  Complete submission text file 0001144204-19-014663.txt   34259
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 000-20713 | Film No.: 19689021
SIC: 2836 Biological Products, (No Diagnostic Substances)